Depression - Articles - Page 9

EXPERT Q&A

Psychiatric Issues in Organ Transplantation

January 2, 2023

Paula C. Zimbrean, MD, FAPA, FACLP

Associate professor of psychiatry and surgery (transplant), Yale University School of Medicine; Chair, Transplant Psychiatry Special Interest Group, Academy of Consultation Psychiatry. New Haven, CT.

Dr. Zimbrean has consulted for Ultragenyx and Vivet Therapeutics, and has consulted and advised for Alexion. Relevant financial relationships listed for the author have been mitigated.

Growing numbers of patients receive organ transplants every year. This Q&A reviews the unique considerations that arise when these patients require psychiatric care.

CLINICAL UPDATE

Management of Depression and Neurocognitive Impairment in Patients With HIV

January 2, 2023

Garrett Rossi, MD.

Garrett Rossi, MD. Inpatient/consult attending psychiatrist, AtlantiCare Regional Medical Center. Pomona, NJ.
Dr. Rossi has no financial relationships with companies related to this material.

Strategies for HIV-associated mood and cognitive changes

CLINICAL UPDATE

Viibryd Goes Generic, But Is It Worth Prescribing?

January 1, 2023

Chris Aiken, MD

Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. Practicing psychiatrist, Winston-Salem, NC. Dr. Aiken has no financial relationships with companies related to this material.

Goodbye Viibryd, hello vilazodone. This novel medication has missed the mark in a lot of trials, but it still has a narrow niche in the crowded field of antidepressants.

Using SAMe in Clinical Practice

November 15, 2022

Garrett Rossi, MD.

0.50 CME Credits. Learn how to prescribe SAMe and how to dose it effectively to achieve the desired result.

CARLAT WEBINAR

Management of Depression During Postpartum and Breastfeeding

November 15, 2022

Victoria Hendrick, MD

0.50 CME Credits. Women who have postpartum depression can find reassurance in knowing there are four evidence-based treatments that are safe for them and their babies.

CARLAT WEBINAR

ECT: Update and Comprehensive Review

November 3, 2022

Stephen J. Seiner, MD

0.50 CME Credits. Advances in ECT have made it safer, more comfortable, and with a better cognitive profile that allowed for its use other than just as a last resort.

RESEARCH UPDATE

Side Effects in Depression

October 30, 2022

Fernando Espí Forcén, MD. Dr. Forcén has no financial relationships with companies related to this material.

Side effects are burdensome to patients, but do they also get in the way of recovery? This study sought to clarify how side effects change over time and whether they impede recovery in major depressive disorder.

EXPERT Q&A

The Enduring Value of Talking Therapy

October 30, 2022

Allen Frances, MD

Allen Frances, MD. Dr. Frances has no financial relationships with companies related to this material.

An interview with Dr. Allen Frances about the enduring value of talk therapy, and insights into how therapy is being used in modern clinical practice.

Throwback Thursday: Ginger Ale and Normal Hallucinations

October 13, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

Is it ever normal to hear voices and is ginger ale really the best treatment for nausea?

How to Identify and Treat Apathy and Late-Life Depression

October 1, 2022

Rehan Aziz, MD and Julia Cromwell, MD

Rehan Aziz, MD. associate program director, geriatric psychiatry fellowship program, Jersey Shore University Medical Center; associate professor of psychiatry and neurology, Hackensack Meridian School of Medicine, Nutley, NJ. Julia Cromwell, MD. Inpatient geriatric psychiatrist, Mass General Brigham Salem Hospital, Salem, MA. Dr. Aziz and Dr. Cromwell, authors of this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.

We provide tips on distinguishing between apathy and depression, as well as recommendations on how to manage these disorders.